Platform technology for early detection of dementia.
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease.
Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.
Visit website: https://www.cognetivity.com/
Cognetivity is also referenced in the following:
People at Cognetivity
OptiMind app designed for early diagnosis of dementia with simple tapping
Wired - 11-Nov-2021
A 5-minute test can assess the early risk of getting dementiaRead more...